Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
CA 2414995 A1 · Owner: Bertilsson, Goran · Inventors: Poellinger, Lorenz; Berkenstam, Anders; Bertilsson, Goran
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates a mammalian polypeptide designated Inhibitory PAS Domain Protein (IPAS) which polypeptide is useful for the inhibition of angiogenesis and/or tumor progression. The invention also relates to screening methods for compounds potentially useful as medicaments for the treatment of medical conditions related to angiogenesis or tumor progression.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.